SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance

Background: Methyltransferase SETDB1 is highly expressed in breast cancer (BC), however, the mechanisms by which SETDB1 promotes BC progression to endocrine therapy resistance remains elusive. In this study, we examined the mechanisms by which SETDB1 contribute to BC endocrine therapy resistance. Me...

Full description

Bibliographic Details
Main Authors: Altwegg, K.A (Author), Chen, Y. (Author), Ebrahimi, B. (Author), He, Y. (Author), Lai, Z. (Author), Li, X. (Author), Liu, J. (Author), Liu, Z. (Author), Pratap, U.P (Author), Rao, M.K (Author), Sareddy, G.R (Author), Shen, L. (Author), Tang, W. (Author), Tekmal, R.R (Author), Vadlamudi, R.K (Author), Viswanadhapalli, S. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Akt
Online Access:View Fulltext in Publisher